
BiondVax Pharmaceuticals Ltd. BVXV
Annual report 2021
added 12-23-2023
BiondVax Pharmaceuticals Ltd. P/CF Ratio 2011-2026 | BVXV
Annual P/CF Ratio BiondVax Pharmaceuticals Ltd.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -30.2 | -0.695 | -1.16 | -0.603 | -3.63 | -1.64 | -0.922 | - | - | - | - |
All numbers in ILS currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.603 | -30.2 | -5.55 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 4.57 | -0.22 % | $ 11 B | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Compugen Ltd.
CGEN
|
6.2 | $ 2.65 | -2.93 % | $ 248 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-3.64 | $ 0.88 | - | $ 6.47 M | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
20.2 | $ 22.5 | -0.75 % | $ 3.73 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Galapagos NV
GLPG
|
-8.78 | $ 27.55 | -3.08 % | $ 2.69 B | ||
|
Genmab A/S
GMAB
|
4.08 | $ 25.89 | -3.36 % | $ 16 B | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.142 | - | 17.91 % | $ 11.1 M | ||
|
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 100.4 | -1.63 % | $ 27.2 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Innoviva
INVA
|
8.24 | $ 23.23 | -1.94 % | $ 1.57 B | ||
|
Innate Pharma S.A.
IPHA
|
-6.2 | $ 1.45 | 3.57 % | $ 235 M | ||
|
Aquestive Therapeutics
AQST
|
-8.91 | $ 4.07 | -0.61 % | $ 435 M | ||
|
Inventiva S.A.
IVA
|
-11.2 | $ 4.96 | -1.1 % | $ 138 M | ||
|
Jaguar Health
JAGX
|
-0.0404 | $ 0.23 | -5.27 % | $ 536 K | ||
|
Arcutis Biotherapeutics
ARQT
|
-612 | $ 22.56 | -3.13 % | $ 2.87 B | ||
|
KalVista Pharmaceuticals
KALV
|
-10.2 | $ 26.71 | 38.8 % | $ 1.44 B | ||
|
Autolus Therapeutics plc
AUTL
|
-1.14 | $ 1.4 | -5.74 % | $ 373 M | ||
|
Kamada Ltd.
KMDA
|
-30.7 | $ 8.15 | - | $ 260 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
13.6 | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 2.88 | -1.03 % | $ 4.74 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B |